CClinicalTrials.gg
CompletedNCT07503418Updated Mar 31, 2026

Enhancing Nursing Students' Empathy and Learning in Parkinson's Disease Through High-Fidelity Simulation and Blended Learning

An interventional study of Blended-learning capsules and High-Fidelity Physical Simulation in Parkinson Disease (PD), sponsored by University of Cadiz. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by University of Cadiz · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Feb 2025, registered Mar 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this randomized controlled trial is to evaluate the effectiveness of a multimodal Parkinson's disease-focused intervention on empathy levels and perceived theoretical-practical learning in third-year undergraduate nursing students.

The main questions it aims to answer are:

  • Will students receiving the multimodal intervention demonstrate significantly higher levels of clinical empathy compared to those receiving standard simulation-based workshops?
  • Will the intervention significantly improve awareness of Parkinson's disease (PD) quality of life and the internalisation of the patient's lived experience?

Researchers will compare the experimental group, which receives a multimodal approach including blended learning and a simulated home environment, to a control group receiving standard simulation workshops on physiological aging to see if the multimodal strategy offers superior outcomes in clinical awareness and empathy development.

Participants will:

  • Attend a two-hour initial theoretical session regarding neurodegenerative disorders and nursing care.
  • Complete digital blended-learning micro-capsules covering PD pathophysiology and authentic patient testimonials (Experimental Group only).
  • Engage in high-fidelity physical simulation using GERT® suits to perform activities of daily living (e.g., dressing, eating, and walking) within either a recreated domestic environment or a standard classroom setting.
  • Participate in a structured debriefing session focused on reflective analysis of the emotional and functional impact of Parkinson's symptoms.
  • Complete validated self-administered instruments during pretest and posttest phases to measure empathy, satisfaction, and perception of learning.
Read the detailed description

This study describes a randomized controlled trial designed to address the urgent need for specialized nursing education as the global prevalence of Parkinson's disease (PD) continues to rise. Researchers aim to evaluate how a multimodal intervention-combining digital learning with immersive simulation-affects the clinical empathy and theoretical-practical understanding of third-year nursing students.

The challenge of Parkinson's Disease Parkinson's disease is a complex neurodegenerative disorder characterized by an unpredictable array of motor and non-motor symptoms. As the global burden of PD is projected to double by 2040, healthcare systems require nurses who possess not only technical skills but also a deep, humanized understanding of the patient's lived experience. Traditional educational methods often leave a gap in preparing students for the specific challenges of person-centered neurodegenerative care.

Study Design and Participants The study will involve 84 third-year nursing students from the University of Cadiz in Spain. These participants will be randomly assign to either a control group or an experimental group. While both groups will receive two hours of initial theoretical instruction on neurodegenerative disorders, their practical training will differ significantly.

The Multimodal Intervention

The experimental group will participate in a comprehensive, high-fidelity simulation experience designed to maximize psychological fidelity. This multimodal approach includes three key components:

  • Blended-Learning Capsules: Students will access digital modules featuring authentic patient testimonials to provide a real-world context for PD pathophysiology.
  • GERT® Geriatric Suits: Students will wear specialized suits designed to physically simulate the motor limitations and tremors associated with PD.
  • Simulated Home Environment: Unlike the control group, who will practice in a standard classroom, the experimental group will perform activities of daily living-such as eating, dressing, and walking-within a room designed to look like a domestic home.

Following these activities, all students will participate in a structured debriefing, a reflective session where they will analyze the emotional and functional impact of the symptoms they will experience.

02

Conditions studied

  • Parkinson Disease (PD)

Browse trials for

Keywords

  • Empathy
  • High Fidelity Simulation Training
  • Nursing Education Research
  • Parkinson Disease
  • Patient Simulation
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,081 are open to participants now.

This study's enrollment of 84 is above the median of 40 across 3,293 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University of Cadiz is the lead sponsor of 55 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Third-year undergraduate nursing students enrolled in Geriatric Nursing subject from a Faculty of Nursing of the University of Cadiz (Spain).

Exclusion criteria

Exclusion Criteria:

  • Participants who do not wish to take part in the study.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Experimental group

    Experimental Group (EG) will perform a multimodal simulation experience.

    Other: Blended-learning capsules · Other: High-Fidelity Physical Simulation · Other: Simulated Home Environment

  • No intervention
    Control Group

    Control Group will participate in a standard workshop on physiological ageing using GERT® simulators.

Interventions

  • OtherBlended-learning capsules

    Digital learning modules covering PD pathophysiology and authentic patient testimonials through audiovisual pills co-developed with the "Santa Adela" Parkinson's Association

  • OtherHigh-Fidelity Physical Simulation

    Using GERT® geriatric suits specifically configured to simulate PD symptoms.

  • OtherSimulated Home Environment

    The EG simulation workshop was delivered in a home-visit simulation room designed to resemble a domestic setting, furnished with household-style equipment and furniture

06

What researchers measure

Primary outcomes

  1. Clinical empathy

    Clinical empathy will be measured by the Jefferson Scale of Physician Empathy (JSPE), validated into Spanish. It is made up of 20 items with scoring using a 7-points Likert scale (1 = strongly disagree, 7 = strongly agree). Ten of the 20 questions are valued negatively (and rectified positively in the subsequent analysis), in order to reduce the effect of acquiescence when responding. The range of possible scores goes from 20 to 140 points. The highest scores are associated with a greater degree of empathy.

    Time frame: Day 1 (pretest) and Day 3 (post-test).

  2. Awareness of Parkinson Disease quality of life

    It will measure by the Parkinson's Disease Questionnaire (PDQ-39), validated into Spanish. The PDQ-39 questionnaire assesses how often people with Parkinson's experience difficulties across 8 dimensions of daily living including relationships, social situations and communication. Although it is an instrument originally conceived as a patient-reported measure of health-related quality of life, students will asked to complete it by "taking the perspective" as if they were patients with the disease. Scores are expressed as a percentage, ranging from 0 (never have difficulty) to 100 (always have difficulty), with lower scores indicating better quality of life and higher scores indicating greater impairment.

    Time frame: Day 1 (pretest) and Day 3 (post-test).

Secondary outcomes

  1. Learning perception

    It will measure by the Educational Practices Questionnaire (EPQ). The scale consists of sixteen questions divided into the following subscales: Active Learning (items 1-10), Collaboration (items 11 and 12), Diverse Learning Methods (items 13 and 14), and High Expectations (items 15 and 16). Furthermore, the scale is divided into two parts. One of these concerns the presence of statements given during simulation classes (EPQ-PO), and the other one concerns their validity, in the student's opinion, during the classes (EPQ-IO). Higher scores mean greater recognition of educational best practices in simulations.

    Time frame: Day 3 (post-test).

  2. Satisfaction with the simulations

    It will measure by the Spanish version of the High-Fidelity Simulation Satisfaction Scale for Students (ESSAF). This scale contains 33 statements answered on a 5-point Likert-type scale, with a minimum score of 1 (strongly disagree) to 5 (strongly agree). The 33 items are grouped into 8 dimensions of student perception of clinical simulation: "Usefulness", "Characteristics of cases and applications", "Communication", "Perceived performance", "Increased self-confidence", "Relationship between theory and practice", "Facilities and equipment" and "Negative aspects". Higher scores indicating greater satisfaction.

    Time frame: Day 3 (post-test).

07

Study locations

1 site
  • Faculty of Nursing
    Algeciras, Cadiz 11207, Spain
08

References and documents

Publications

  • Ward J, Schaal M, Sullivan J, Bowen ME, Erdmann JB, Hojat M. Reliability and validity of the Jefferson Scale of Empathy in undergraduate nursing students. J Nurs Meas. 2009;17(1):73-88. doi: 10.1891/1061-3749.17.1.73. PubMed 19902660 ↗
  • Wang Y, Wang C, Yang Z, Tang Y, Chen W, Zheng Y, Wei Z, Li H. Latent profile analysis of empathy ability and its relationship with professional quality of life among hospice nurses in China. BMC Nurs. 2024 Sep 16;23(1):658. doi: 10.1186/s12912-024-02299-9. PubMed 39285294 ↗
  • Wang R, Raman A. Systematic literature review on the effects of blended learning in nursing education. Nurse Educ Pract. 2025 Jan;82:104238. doi: 10.1016/j.nepr.2024.104238. Epub 2024 Dec 16. PubMed 39700839 ↗
  • Vangone I, Arrigoni C, Magon A, Conte G, Russo S, Belloni S, Stievano A, Alfes CM, Caruso R. The efficacy of high-fidelity simulation on knowledge and performance in undergraduate nursing students: An umbrella review of systematic reviews and meta-analysis. Nurse Educ Today. 2024 Aug;139:106231. doi: 10.1016/j.nedt.2024.106231. Epub 2024 Apr 30. PubMed 38701671 ↗
  • van Munster M, Czabanowska K, Clemens T, Wieczorek E, Pedrosa D, Mestre TA, Stumpel J. Priorities in healthcare provision in Parkinson's disease from the perspective of Parkinson Nurses: A focus group study. Int J Nurs Stud Adv. 2024 Jun 12;7:100213. doi: 10.1016/j.ijnsa.2024.100213. eCollection 2024 Dec. PubMed 39161697 ↗
  • Tosin MHS, Mecone CAC, Oliveira EFM, Tsui DS, Tan SB, Irene S, Oliveira BC, de Oliveira BGRB. Nursing and Parkinson's Disease: A Scoping Review of Worldwide Studies. Clin Nurs Res. 2022 Feb;31(2):230-238. doi: 10.1177/10547738211044047. Epub 2021 Sep 6. PubMed 34486425 ↗
  • Tolosa E, Garrido A, Scholz SW, Poewe W. Challenges in the diagnosis of Parkinson's disease. Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2. PubMed 33894193 ↗
  • Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T. Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ. 2025 Mar 5;388:e080952. doi: 10.1136/bmj-2024-080952. PubMed 40044233 ↗
  • Martinez-Martin P, Frades Payo B. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. The Grupo Centro for Study of Movement Disorders. J Neurol. 1998 May;245 Suppl 1:S34-8. doi: 10.1007/pl00007737. PubMed 9617722 ↗
  • Martinez-Arce A, Rodriguez-Almagro J, Velez-Velez E, Rodriguez-Gomez P, Tovar-Reinoso A, Hernandez-Martinez A. Validation of a short version of the high-fidelity simulation satisfaction scale in nursing students. BMC Nurs. 2023 Sep 28;22(1):344. doi: 10.1186/s12912-023-01515-2. PubMed 37770843 ↗
  • Li YY, Au ML, Tong LK, Ng WI, Wang SC. High-fidelity simulation in undergraduate nursing education: A meta-analysis. Nurse Educ Today. 2022 Apr;111:105291. doi: 10.1016/j.nedt.2022.105291. Epub 2022 Feb 3. PubMed 35158134 ↗
  • Levett-Jones T, Cant R, Lapkin S. A systematic review of the effectiveness of empathy education for undergraduate nursing students. Nurse Educ Today. 2019 Apr;75:80-94. doi: 10.1016/j.nedt.2019.01.006. Epub 2019 Jan 26. PubMed 30739841 ↗
  • Hopewell S, Chan AW, Collins GS, Hrobjartsson A, Moher D, Schulz KF, Tunn R, Aggarwal R, Berkwits M, Berlin JA, Bhandari N, Butcher NJ, Campbell MK, Chidebe RCW, Elbourne D, Farmer A, Fergusson DA, Golub RM, Goodman SN, Hoffmann TC, Ioannidis JPA, Kahan BC, Knowles RL, Lamb SE, Lewis S, Loder E, Offringa M, Ravaud P, Richards DP, Rockhold FW, Schriger DL, Siegried NL, Staniszewska S, Taylor RS, Thabane L, Torgerson D, Vohra S, White IR, Boutron I. CONSORT 2025 statement: Updated guideline for reporting randomised trials. PLoS Med. 2025 Apr 14;22(4):e1004587. doi: 10.1371/journal.pmed.1004587. eCollection 2025 Apr. PubMed 40228477 ↗
  • Farres-Tarafa M, Roldan-Merino J, Lorenzo-Seva U, Hurtado-Pardos B, Biurrun-Garrido A, Molina-Raya L, Morera-Pomarede MJ, Bande D, Raurell-Torreda M, Casas I. Reliability and validity study of the Spanish adaptation of the "Educational Practices Questionnaire" (EPQ). PLoS One. 2020 Sep 17;15(9):e0239014. doi: 10.1371/journal.pone.0239014. eCollection 2020. PubMed 32941464 ↗
  • Crooks S, Stark P, Carlisle S, McMullan J, Copeland S, Wong WYA, Blake D, Lyons E, Campbell N, Carter G, Wilson CB, Mitchell G. Evaluation of a co-designed Parkinson's awareness audio podcast for undergraduate nursing students in Northern Ireland. BMC Nurs. 2023 Oct 9;22(1):370. doi: 10.1186/s12912-023-01544-x. PubMed 37814245 ↗
  • Baghaei A, Kim HS, Dolhun R, Sherzai D, Dashtipour K. Review of the Effects of Lifestyle Modification on Parkinson's Disease. Am J Lifestyle Med. 2025 Oct 3:15598276251384591. doi: 10.1177/15598276251384591. Online ahead of print. PubMed 41050191 ↗

Individual participant data

Plan to share: Yes — The dataset compiled during the study, which has been appropriately processed to ensure the anonymity of the participants, will be made openly available when the study results are published.

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07503418
Lead sponsor
University of Cadiz
Responsible party
Antonio Jesús Marín Paz (Collaborator investigator, University of Cadiz) — Principal investigator
First posted
Mar 31, 2026
Start date
Feb 1, 2025
Primary completion
May 31, 2025
Completion
Jun 30, 2025
Last update
Mar 31, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion